TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 107 filers reported holding TARSUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,140,586 | $38,038,213 | 5.37% |
| Vivo Capital, LLC | 2,262,200 | $40,199,294 | 4.40% |
| TCG Crossover Management, LLC | 1,142,857 | $20,308,569 | 2.99% |
| Cormorant Asset Management, LP | 2,621,422 | $46,582,669 | 2.72% |
| Ghost Tree Capital, LLC | 400,000 | $7,108,000 | 2.34% |
| COWEN AND COMPANY, LLC | 1,796,773 | $31,928,656 | 2.23% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $31,764,355 | 2.11% |
| TFG Asset Management GP Ltd | 615,000 | $10,928,550 | 1.99% |
| Sands Capital Ventures, LLC | 260,000 | $4,620,200 | 1.37% |
| Ikarian Capital, LLC | 518,519 | $9,214,083 | 1.11% |
| RTW INVESTMENTS, LP | 2,880,701 | $51,190,057 | 1.08% |
| Perceptive Advisors | 1,296,416 | $23,037,312 | 0.77% |
| Endurant Capital Management LP | 47,649 | $846,723 | 0.76% |
| Grant/GrossMendelsohn, LLC | 53,610 | $952,650 | 0.41% |
| Soleus Capital Management, L.P. | 250,000 | $4,442,500 | 0.41% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 754,042 | $13,399,326 | 0.30% |
| Nantahala Capital Management | 135,500 | $2,407,835 | 0.21% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 43,707 | $776,673 | 0.10% |
| Ghisallo Capital Management LLC | 50,000 | $888,500 | 0.09% |
| J. Goldman & Co LP | 125,909 | $2,237,403 | 0.08% |
External links
This page lists TARSUS PHARMACEUTICALS INC's shareholders in Q3 2023. To view TARSUS PHARMACEUTICALS INC's shareholder history, click here.